Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
2.665
-0.165 (-5.83%)
At close: May 14, 2025, 4:00 PM
2.690
+0.025 (0.94%)
After-hours: May 14, 2025, 4:20 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $88.45 million as of May 14, 2025. Its market cap has decreased by -78.52% in one year.
Market Cap
88.45M
Enterprise Value
3.49M
1-Year Change
-78.52%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $88.45M, a decrease of -67.41%. That is a compound annual growth rate of -52.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 93.92M | -56.85% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |